Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131

BMC Cancer201313:143

DOI: 10.1186/1471-2407-13-143

Received: 13 July 2012

Accepted: 30 January 2013

Published: 22 March 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
8 Aug 2012 Reviewed Reviewer Report - Dongmei He
9 Nov 2012 Reviewed Reviewer Report - Catherine Brenner
3 Dec 2012 Author responded Author comments - Yong Hyun Jeon
Resubmission - Version 4
3 Dec 2012 Submitted Manuscript version 4
7 Dec 2012 Reviewed Reviewer Report - Dongmei He
2 Jan 2013 Author responded Author comments - Yong Hyun Jeon
Resubmission - Version 5
2 Jan 2013 Submitted Manuscript version 5
2 Jan 2013 Author responded Author comments - Yong Hyun Jeon
Resubmission - Version 6
2 Jan 2013 Submitted Manuscript version 6
6 Jan 2013 Reviewed Reviewer Report - Dongmei He
15 Jan 2013 Author responded Author comments - Yong Hyun Jeon
Resubmission - Version 7
15 Jan 2013 Submitted Manuscript version 7
Publishing
30 Jan 2013 Editorially accepted
22 Mar 2013 Article published 10.1186/1471-2407-13-143

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pathology, Seoul National University College of Medicine
(2)
Department of Nuclear Medicine, Kyungpook National University
(3)
Leading-edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University

Advertisement